Journal
CLINICAL RHEUMATOLOGY
Volume 26, Issue 7, Pages 1127-1129Publisher
SPRINGER
DOI: 10.1007/s10067-006-0412-1
Keywords
anti-TNF-alpha; cyclosporine A; HCV; rheumatoid arthritis
Categories
Ask authors/readers for more resources
We describe two cases of rheumatoid arthritis (RA) patients and concomitant hepatitis C virus infection (HCV), treated with cyclosporine A (CsA) and anti-TNF-alpha agents. SGOT/SGPT and HCV-RNA serum levels remained unchanged longer than 1 year of treatment. No side effects were registered. We suggest that combination therapy with CsA and TNF-alpha blockers should be considered safe and well-tolerated in the treatment of HCV-positive RA patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available